Molecular Study of the Maternal-fetal Interface in Preeclampsia. | MicrobiomeTrials← Back to trialsNCT06232668
Molecular Study of the Maternal-fetal Interface in Preeclampsia.
RecruitingOBSERVATIONAL
Trial Details
Start: 2023-11-20Est. Completion: 2027-12
Enrollment target: 2,084 participants Locations- Hospital General Universitario Dr. Balmis, Alicante, Alicante, Spain
- Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, Murcia, Spain
- Hospital Universitario de Canarias, Santa Cruz de Tenerife, Santa Cruz de Tenerife, Spain
- Hospital Universitario y Politécnico La Fe, Valencia, Valencia, Spain
ContactCarlos Simón, MD, PhD
Other microbiome trials you might be interested in
Malaria
Malaria caused by Plasmodium falciparum continues to be a global problem with devastating consequences. A greater unders…
Bamako, Mali
Hypertensive Disorder of PregnancyPreeclampsia
The purpose of this study is to compare latency (prolongation of pregnancy from diagnosis till delivery) in patients wit…
Columbus, United StatesEst. completion Dec 2027
Hypertensive Disorders of PregnancyPreeclampsiaGestational Hypertension
The objective is to conduct a double-blinded randomized controlled trial of atorvastatin vs. placebo among postpartum in…
Columbus, United StatesEst. completion Sep 15, 2027